Matthew Keller

Matthew Keller

Auto-generated profile, based on publicly available information

Matthew Keller

Department of Medicine, Division of Infectious Diseases Washington University School of Medicine St. Louis Missouri USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 June 2020 in Journal of Bone and Joint Surgery
Verified
Journal Article
Closed access
CDChristopher J. Dy
Christopher J. Dy
ABAbigail R. Barker
Abigail R. Barker
DBDerek S. Brown
Derek S. Brown
MKMatthew Keller
Matthew Keller
PCPeter Chang
Peter Chang
MOMargaret A. Olsen
Margaret A. Olsen
Background: The utilization of total hip arthroplasty (THA) and total knee arthroplasty (TKA) increased after Medicaid expansion under the U.S. Affordable Care Act (ACA), suggesting a potential unmet need for THA and TKA. We examined the timing of THA and TKA in patients after obtaining Medicaid expansion insurance coverage. We hypothesized that patients with Medicaid expansion insurance would undergo a surgical procedure sooner than patients in traditional Medicaid populations. Methods: We used administrative data from a Medicaid managed care company to determine the timing of primary THA and TKA in patients who were 18 to 64 years of age in 4 states with Medicaid expansion (Illinois, Ohio, Oregon, and Washington) and 4 states without Medicaid expansion (Louisiana, Mississippi, Texas, and Wisconsin) from 2008 to 2015. The insurance types were Medicaid expansion, Medicaid plans for Supplemental Security Income (SSI), or Temporary Assistance for Needy Families (TANF). Roughly, these 3 groups correspond to relatively healthy childless adults, relatively unhealthy disabled adults, and parents of children with Medicaid insurance. The main outcome measure was time from enrollment to the surgical procedure. The primary exposure of interest was insurance type. We used a generalized linear regression model to adjust for patient age, sex, social deprivation, surgeon supply and reimbursement, and state-level Medicaid enrollment. Results: In the unadjusted analysis of 4,117 patients, there was a significantly shorter time from enrollment to THA and TKA for the expansion group (median, 7.5 months) relative to the SSI group (median, 16.1 months; p < 0.0001) and the TANF group (median, 12.2 months; p < 0.0001). In the adjusted analysis, the time from enrollment to THA and TKA was significantly shorter in the expansion group (β, −1.21 [95% confidence interval (CI), −1.35 to −1.07]; p < 0.001) compared with the TANF group (β, −0.27 [95% CI, −0.38 to −0.17]; p < 0.001) and the SSI group (reference). Compared with the SSI group, these coefficients are equivalent to a 70% shorter time to the surgical procedure in the expansion group and a 24% shorter time to the surgical procedure in the TANF group. Conclusions: Our findings suggest an unmet need for THA and TKA among newly enrolled Medicaid expansion beneficiaries. This need should be considered by surgeons, hospitals, and policymakers in ensuring access to care. Furthermore, consideration should be given to existing insurance-based disparities in access to orthopaedic care, as these may be exacerbated by an increased demand for THA and TKA from Medicaid expansion beneficiaries.

20 January 2021 in Journal of Bone and Joint Surgery
Verified
Journal Article
Closed access
CDChristopher J. Dy
Christopher J. Dy
ASAmber Salter
Amber Salter
ABAbigail R. Barker
Abigail R. Barker
DBDerek S. Brown
Derek S. Brown
MKMatthew Keller
Matthew Keller
MOMargaret A. Olsen
Margaret A. Olsen
Background: The expansion of state Medicaid programs under the U.S. Affordable Care Act has led to a dramatic increase in the number of Americans with health insurance coverage. Prior analyses of a limited number of states have suggested that greater utilization of total hip arthroplasty (THA) and total knee arthroplasty (TKA) should be expected after Medicaid expansion. The purpose of our study was to examine whether increased utilization of THA and TKA occurred across a broader range of states after Medicaid expansion. Methods: We analyzed administrative data from the Healthcare Cost and Utilization Project from 9 states (Arkansas, Arizona, Colorado, Iowa, Massachusetts, Maryland, Nevada, New York, and Vermont) that expanded Medicaid in 2014 and 2 states that did not expand Medicaid (Florida and Missouri). We included patients who were 18 to 64 years of age and had a primary THA or TKA from 2012 to 2015 with Medicaid as the primary payer. Other payers (including dual-eligible Medicaid and Medicare beneficiaries) were excluded. We performed multivariable regression modeling with the number of Medicaid-insured THAs or TKAs as the dependent variable and the interaction between the state Medicaid expansion status and year as the main policy independent variable, with adjustment for community characteristics. Results: Among all 11 states, there were 39,452 total joint arthroplasties (42% THA and 58% TKA) funded by Medicaid from 2012 to 2015. After adjusting for community characteristics, within expansion states, compared with 2013, THA and TKA increased 15% in 2014 (p < 0.0001) and 23% in 2015 (p < 0.0001) within expansion states. Within non-expansion states, compared with 2013, there were significant utilization decreases of 18% in 2014 (p < 0.0001) and 11% in 2015 (p = 0.0002). Conclusions: Medicaid expansion was associated with significant increases in Medicaid-funded THA and TKA utilization in 9 states. As additional states consider expanding Medicaid programs and as alternative health reforms that increase insurance eligibility are debated, surgeons, administrators, and policymakers should prepare for a surge in the utilization of THA and TKA.

13 April 2021 in Pharmacoepidemiology and Drug Safety
Verified
Journal Article
Open access
PDF file
ABAnne M. Butler
Anne M. Butler
MDMichael J. Durkin
Michael J. Durkin
MKMatthew R. Keller
Matthew R. Keller
YMYinjiao Ma
Yinjiao Ma
VDVikas R. Dharnidharka
Vikas R. Dharnidharka
MOMargaret A. Olsen
Margaret A. Olsen
Purpose: Acute uncomplicated urinary tract infections (UTIs) are among the most common indications for antibiotic prescriptions in otherwise healthy women. We compared the risk of treatment failure of antibiotic regimens for outpatient treatment of UTI in real‐world practice.Methods: We identified non‐pregnant, premenopausal women diagnosed with uncomplicated, lower tract UTI and prescribed an oral antibiotic with activity against common uropathogens. We used propensity score‐weighted Kaplan–Meier functions to estimate 30‐day risks and risk differences (RD) for pyelonephritis and UTI‐related antibiotic prescription switch.Results: Of 1 140 602 patients, the distribution of index prescriptions was 44% fluoroquinolones (non‐first‐line), 28% trimethoprim‐sulfamethoxazole (TMP/SMX) (first‐line), 24% nitrofurantoin (first‐line), 3% narrow‐spectrum β‐lactams (non‐first‐line), 1% broad‐spectrum β‐lactams (non‐first‐line), and 1% amoxicillin/ampicillin (non‐recommended). Compared to the risk of pyelonephritis for nitrofurantoin (0.3%), risks were higher for TMP/SMX (RD, 0.2%; 95% CI, 0.2%–0.2%) and broad‐spectrum β‐lactams (RD, 0.2%; 95% CI, 0.1%–0.4%). Compared to the risk of prescription switch for nitrofurantoin (12.7%), the risk was higher for TMP/SMX (RD 1.6%; 95% CI 1.3%–1.7%) but similar for broad‐spectrum β‐lactams (RD −0.7%; 95% CI −1.4%‐0.1%) and narrow‐spectrum β‐lactams (RD −0.3%; 95% CI −0.8%–0.2%). Subgroup analyses suggest TMP/SMX treatment failure may be due in part to increasing uropathogen resistance over time.Conclusions: The risk of treatment failure differed by antibiotic agent, with higher risk associated with TMP/SMX versus nitrofurantoin, and lower or similar risk associated with broad‐ versus narrow‐spectrum β‐lactams. Given serious safety warnings for fluoroquinolones, these results suggest that nitrofurantoin may be preferable as the first‐line agent for outpatient treatment of uncomplicated UTI.